20-F: Registration statement / Annual report / Transition report
6-K: Report of foreign private issuer (related to financial reporting)
EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption
Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ: LAX, the "Company"), a special purpose acquisition company, announced today that all proposals presented to shareholders
8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period
Singapore, May 31, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited, a Singapore-based digital health platform that aims to make healt
8i Acquisition 2 Corp. to Combine with EUDA Health Limited to Bring a Leading Digital Health Platform Servicing Southeast Asia to the Public Market
EUDA Health is disrupting the multi-trillion-dollar Southeast Asia healthcare industry with its proprietary unified AI platform that makes healthcare affordable, accessible, and personalized across So
No Data